Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07548008
Active, not recruiting Observational

Ferric Sulfate and Sodium Hypochlorite Pulpotomies in Vital Primary Teeth

NCT07548008 · tracked via the Priya Life Science Turkey tracker
Sponsor
Marmara University
Phase
Observational
Started
2025-08-10
Last updated
2026-04-23

Condition(s) studied

Dental CariesPulpotomies Primary Teeth

Study summary

This study aims to compare the clinical and radiographic success of two commonly used pulpotomy agents, ferric sulfate (FS) and sodium hypochlorite (NaOCl), in vital primary molars. Pulpotomy is a widely used vital pulp therapy procedure in pediatric dentistry to preserve primary teeth until their natural exfoliation.

The study will include children aged 4-9 years who previously received pulpotomy treatment using either FS or NaOCl at Marmara University Faculty of Dentistry. No additional treatment will be performed as part of this study. Patients will be followed during routine clinical visits at 6, 12, and 24 months.

Clinical outcomes such as pain, mobility, and infection, as well as radiographic findings including resorption and radiolucency, will be evaluated. The results of this study are expected to provide evidence for the effectiveness of these materials and support clinical decision-making in pediatric dental practice.

Eligibility

Sex
ALL
Min age
4 Years
Max age
9 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged 4-9 years * Patients who received pulpotomy treatment in vital primary molars using 15.5% ferric sulfate or 5% sodium hypochlorite between January and April 2025 Availability of preoperative diagnostic periapical radiographs of adequate quality * Complete clinical records of the pulpotomy procedure * Patients who attended or agreed to attend follow-up visits at 6, 12, and 24 months * Cases in which the treatment protocol and materials used were clearly documented Exclusion Criteria: * Incomplete or poor-quality clinical and/or radiographic records * Presence of systemic diseases (e.g., immunosuppression, uncontrolled systemic conditions) * History of allergy or hypersensitivity to ferric sulfate or sodium hypochlorite * Teeth with intraoperative complications (e.g., perforation, uncontrolled bleeding, or change in treatment plan) * Teeth with pulp exposure due to trauma (only caries-related cases included) * Patients who did not attend follow-up visits or attended only one follow-up visit

Primary outcome measure(s)

  • Clinical and Radiographic Success Rate of Pulpotomy — 24 months
    The primary outcome is the clinical and radiographic success of pulpotomy-treated primary teeth. Clinical success is defined as the absence of pain, mobility, fistula, abscess, or tenderness to percussion. Radiographic success is defined as the absence of internal or external resorption, periapical or furcal radiolucency, and other pathological findings.

Trial sites (1)

FacilityCityRegionStatus
Marmara University Istanbul Turkey (Türkiye)

More Marmara University trials in Turkey

Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema Recruiting
AI-Based Prediction of Root Coverage Outcome From Intraoral Photographs Recruiting
Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision Active, not recruiting
The Effect of Inspiratory Exercises on Diaphragm and Intercostal Muscle Thickness in Stroke Patients Starting soon
Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia Enrolling by invitation

Other trials for the same condition

Clinical Comparison of Restorative Materials Active, not recruiting
Clinical Evaluation of the Retention of Fissure Sealants Applied Following Guided Biofilm Therapy and Conventional Polishing Starting soon
Hall Technique vs Conventional Technique in Permanent Teeth Starting soon
DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN GINGIVAL CREVICULAR FLUID Starting soon
Comparison of Clinical Performance of Partial Restorations Fabricated With Three-Dimensional Printer and CAD-CAM Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07548008 on ClinicalTrials.gov ↗ ← All trials in Turkey